Security key
457637601
InMed Pharmaceuticals Inc. - Common Shares, no par value (INM)
CUSIP: 457637601
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 1,141,865
- Total 13F value
- $265,983
- Share change
- +701,594
- SEC-reported price per share
- $0.24
- Number of holders
- 12
- Value change
- +$152,049
- Number of buys
- 7
- Number of sells
- 5
- Shares outstanding
- 804,525
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
12
Top holders
10
INM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
InMed Pharmaceuticals Inc. SEC filings
InMed Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 457637601
Recent filing periods:
Ownership snapshot
Top reported holders of INM - InMed Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
SABBY MANAGEMENT, LLC
Comparable rows
12/15
Latest evidence
31 Jul 2024
13F
3/4/5
Lead comparable stake: 38%
3 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
SABBY MANAGEMENT, LLC leads the comparable SEC ownership view at 38%.
12 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SABBY MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 5
SABBY MANAGEMENT, LLC
38%
Virtu Financial LLC
11%
XTX Topco Ltd
2.2%
HRT FINANCIAL LP
2%
CITADEL ADVISORS LLC
1.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
Company
|
38%
|
$81,571
307,236 shares
|
— | 30 Jun 2024 |
| Virtu Financial LLC |
13F
Company
|
11%
|
$23,000
86,684 shares
|
— | 30 Jun 2024 |
| XTX Topco Ltd |
13F
Company
|
2.2%
|
$4,731
17,819 shares
|
— | 30 Jun 2024 |
| HRT FINANCIAL LP |
13F
Company
|
2%
|
$4,000
15,996 shares
|
— | 30 Jun 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
1.5%
|
$3,212
12,097 shares
|
— | 30 Jun 2024 |
| Qube Research & Technologies Ltd |
13F
Company
|
0.02%
|
$54
200 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
12
Shares
1,141,865
Rows available
12
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
10
Q3 2024 holders
12
Holder diff
2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend